Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome

Nat Clin Pract Endocrinol Metab. 2006 Mar;2(3):160-71. doi: 10.1038/ncpendmet0119.

Abstract

Kallmann syndrome (KS) is a disorder characterized by hypogonadotropic hypogonadism and anosmia. Although KS is genetically heterogeneous, only two causal genes have been identified to date. These include an X-linked gene that encodes anosmin 1 and an autosomal gene that encodes fibroblast growth factor receptor 1. Mutations in these two genes result in disorders that often include, but are not limited to, severe defects in olfactory and reproductive functions. In this respect, KS can be regarded as a 'human model' for understanding critical factors that regulate olfactory and reproductive development. Here we give an overview of the disorders that stem from mutations in these two genes, with special emphasis on the cellular mechanisms underlying olfactory and reproductive anomalies. Other, less well-known aspects of KS, such as the convergence of symptoms in patients with different genetic forms of KS and the unpredictable manifestation of KS symptoms, are also discussed.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Extracellular Matrix Proteins / genetics
  • Extracellular Matrix Proteins / physiology
  • Genes, X-Linked*
  • Humans
  • Kallmann Syndrome / diagnosis
  • Kallmann Syndrome / genetics*
  • Kallmann Syndrome / therapy
  • Mutation
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology
  • Phenotype
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Receptor, Fibroblast Growth Factor, Type 1 / physiology

Substances

  • ANOS1 protein, human
  • Extracellular Matrix Proteins
  • Nerve Tissue Proteins
  • FGFR1 protein, human
  • Receptor, Fibroblast Growth Factor, Type 1